Development and Improvement of Cerium Activated Gadolinium Gallium Aluminum Garnets Scintillators for Radiation Detectors by Codoping
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Gadolinium Information
Gadolinium Information Gadolinium contrast agents are frequently utilized during MRI examinations in order to improve the exam and interpretation. They are not always needed. Your radiologist will determine whether or not gadolinium contrast is needed for your MRI examination. Gadolinium contrast agents are quickly eliminated from the body in healthy individuals. With normal functioning kidneys, the retention of gadolinium in soft tissues of the body is very small and may not even be detectable. However, some patients who receive multiple doses of contrast, including pregnant women and children, might be at increased risk of gadolinium remaining in the body for longer periods of time. To date, there are no known harmful effects of gadolinium remaining in the body for long periods of time in patients who have normal kidneys. In patients who have poorly functioning kidneys, a condition called nephrogenic systemic sclerosis (NSF) can occur. This causes debilitating thickening of the skin and other tissues. This only occurs in patients with poorly functioning kidneys. Your kidney function will be checked prior to receiving gadolinium contrast agent if needed. Other side-effects can occur even in patients with healthy kidneys. Some patients report pain, tiredness, and muscle aches after receiving gadolinium contrast but these conditions have not been directly linked to the administration of the gadolinium. Allergic reactions can also occur, as with any drug. If you have questions regarding your MRI examination today, please ask your MRI Technologist. MEDICATION GUIDE MULTIHANCE® (məl-tē-han(t)s) (gadobenate dimeglumine) Injection for intravenous use What is MULTIHANCE? • MULTIHANCE is a prescription medicine called a gadolinium-based contrast agent (GBCA). -
DOCUMENT Mute
DOCUMENT mute ED 124 18 . 88 SE 019 612 TITLEN: Radioactivity .and Man iinicourse, Career Oriented Pre-Technical Physics* , INSTITUTI N Dallas Independent School District, Tex. SPONS AGE CY Bureauvof Ele*entary and Secondary tducat4.0n (D5 HEN/OE),-WashingtOn, D.C. -RUB DATE 7 For rilated 0, NOTE - 78p.; Drawings may not reproduce wel documens, see SE 018 322-333 and SE 019 605-616 , . 4 EDRS PRICE MF-$0.83 HC-$4.67 Plus Postag4. DESCRIPTOR Instructional Materialsi Physics; *Program Guides; *Radiation Effects; *Science Activities; Science .41 Careers; Science Education; *Science Materials; Secondary Zdution;.*Secondary School Science; Technical Educe ion IDENTIFIrRS Elementary Seco dart' VIAlcation ACt Title III; ESEA Title' III 07. 1 ABSTRACT .1j This instructional guide, intended for student use, develops the subject of radioactivity and can through a series. of sequential activities.. `A technical development of the subject is pursued with examples stressing practical aspects'of the concepts. Included in the minicourse are:, (1) the rationale,(2) terminal behavioral objectives, (3) enabling behavioral objectives,(4) activities,(5) resource ,packages, and (6) evaluation materials. The' * benefits as well as the dangers of radiometivity to Ian are considered.,This unit is one of twelve intended for use in.the second year of tv9 year vocationally oriented .physics. program. (CP) j t I J ***********************************************************************. * . Documents acquired by ERIC include many inforgal unpublished * materials not a40.1able.from other sources. ERIC makes every effort * * to obtiit the best copy available. Nevertheless,items of.marginel * *.reproducibility are often encountered and this-affects the quality * - *`of the microfiche and hardcopy reproductions ERIC makes available * *. -
Improving the Scintillation Performance of Ksr2i5:Ce3+ Through Exploration of Activator Concentration and Growth Conditions
University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Masters Theses Graduate School 5-2019 Improving the Scintillation Performance of KSr2I5:Ce3+ through Exploration of Activator Concentration and Growth Conditions Eleanor Paige Comer University of Tennessee, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes Recommended Citation Comer, Eleanor Paige, "Improving the Scintillation Performance of KSr2I5:Ce3+ through Exploration of Activator Concentration and Growth Conditions. " Master's Thesis, University of Tennessee, 2019. https://trace.tennessee.edu/utk_gradthes/5414 This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a thesis written by Eleanor Paige Comer entitled "Improving the Scintillation Performance of KSr2I5:Ce3+ through Exploration of Activator Concentration and Growth Conditions." I have examined the final electronic copy of this thesis for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Master of Science, with a major in Nuclear Engineering. Charles L. Melcher, Major Professor We have read this thesis and recommend its acceptance: Mariya Zhuravleva, Eric Lukosi Accepted for the Council: Dixie L. Thompson Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) Improving the Scintillation Performance of KSr2I5:Ce3+ through Exploration of Activator Concentration and Growth Conditions A Thesis Presented for the Master of Science Degree The University of Tennessee, Knoxville Eleanor Paige Comer May 2019 Copyright © 2019 by Eleanor P. -
Gadolinium Speciation
Gadolinium Speciation Peter Caravan Martinos Center for Biomedical Imaging Institute for Innovation in Imaging Massachusetts General Hospital and Harvard Medical School Conflicts of Interest Stock ownership (>5%): Reveal Pharmaceuticals; Collagen Medical; Factor 1A LLC. Research grants: Pfizer; Pliant Pharmaceuticals; Biogen; Agilent; Pharmakea; Siemens. Consulting: Guerbet; Bayer; Collagen Medical; UCB Biopharma; Pfizer. What do we mean by speciation? What is the chemical form of the gadolinium in tissue? Chelated Gd Dissociated Gd The GBCA remains intact Dissociation of the GBCA Gd3+ ion Is Gd bound to a low molecular weight ligand? Is Gd part of some inorganic material like hydroxyapatite? Is Gd bound to a macromolecule? If so, which one? Where is the Gd distributed within tissue? Extra vs intracellular? In which cellular compartments? Why do we care about speciation? • The chemical form of Gd may inform its potential toxicity • Mineralized, insoluble Gd may be less toxic than soluble protein bound Gd (hypothesis) • The chemical form may also inform whether the Gd will be ultimately eliminated. Intact chelate may be expected to eventually clear the body (hypothesis). • The chemical form and location may guide chelation therapy strategies. Hierarchy of relevance of the data Human in vivo Human ex vivo Animal in vivo Animal ex vivo Solutions To model ex vivo Water solutions Tweedle MF. Gadolinium deposition: Is it chelated or dissociated gadolinium? How can we tell? Magn Reson Imaging. 2016;34(10):1377–82. How do GBCAs differ • Thermodynamics: -
ACR Manual on Contrast Media
ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions. -
Cerium Oxide Nanoparticles and Gadolinium Integration
Linköping Studies in Science and Technology Dissertation No. 1997 Peter Eriksson Peter FACULTY OF SCIENCE AND ENGINEERING Linköping Studies in Science and Technology, Dissertation No. 1997, 2019 Cerium Oxide Nanoparticles Department of Physics, Chemistry and Biology (IFM) Linköping University SE-581 83 Linköping, Sweden and Gadolinium Integration Cerium Oxide Integration Nanoparticles and Gadolinium Synthesis, Characterization and Biomedical Applications www.liu.se Peter Eriksson 2019 Linköping Studies in Science and Technology Dissertation No. 1997 Cerium Oxide Nanoparticles and Gadolinium Integration Synthesis, Characterization and Biomedical Applications Peter Eriksson Applied Physics Department of Physics, Chemistry & Biology Linköping University, Sweden Linköping 2019 Front cover: A cerium oxide nanoparticle with integrated gadolinium. Back cover: Cross-section of a gadolinium-cerium oxide nanoparticle and its displayed theragnostic properties: left) cerium undergo redox-reactions to scavenge reactive oxygen species and right) gadolinium shorten the T1-relaxation time of nuclei spins in water molecules. During the course of the research underlying this thesis, Peter Eriksson was enrolled in Forum Scientium, a multidisciplinary doctoral programme at Linköping University, Sweden. © Copyright 2019 Peter Eriksson, unless otherwise noted Peter Eriksson Cerium Oxide Nanoparticles and Gadolinium Integration; Synthesis, Characterization and Biomedical Applications ISBN: 978-91-7685-029-9 ISSN: 0345-7524 Linköping Studies in Science and Technology, -
Toxicological Profile for Zinc
TOXICOLOGICAL PROFILE FOR ZINC U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry August 2005 ZINC ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. ZINC iii UPDATE STATEMENT A Toxicological Profile for Zinc, Draft for Public Comment was released in September 2003. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE Mailstop F-32 Atlanta, Georgia 30333 ZINC vi *Legislative Background The toxicological profiles are developed in response to the Superfund Amendments and Reauthorization Act (SARA) of 1986 (Public law 99-499) which amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund). This public law directed ATSDR to prepare toxicological profiles for hazardous substances most commonly found at facilities on the CERCLA National Priorities List and that pose the most significant potential threat to human health, as determined by ATSDR and the EPA. The availability of the revised priority list of 275 hazardous substances was announced in the Federal Register on November 17, 1997 (62 FR 61332). For prior versions of the list of substances, see Federal Register notices dated April 29, 1996 (61 FR 18744); April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); and February 28, 1994 (59 FR 9486). -
Evaluating the Potential of Chelation Therapy to Prevent and Treat
www.nature.com/scientificreports OPEN Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from Received: 29 December 2017 Accepted: 23 February 2018 MRI contrast agents Published: xx xx xxxx Julian A. Rees1, Gauthier J.-P. Deblonde1, Dahlia D. An 1, Camille Ansoborlo1, Stacey S. Gauny1 & Rebecca J. Abergel1,2 Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd- based contrast agents (GBCAs) for MRI, prompting the European Medicines Agency to recommend discontinuing the use of over half of the GBCAs currently approved for clinical applications. To address this problem, we fnd that the orally-available metal decorporation agent 3,4,3-LI(1,2- HOPO) demonstrates superior efcacy at chelating and removing Gd from the body compared to diethylenetriaminepentaacetic acid, a ligand commonly used in the United States in the GBCA Gadopentetate (Magnevist). Using the radiotracer 153Gd to obtain precise biodistribution data, the results herein, supported by speciation simulations, suggest that the prophylactic or post-hoc therapeutic use of 3,4,3-LI(1,2-HOPO) may provide a means to mitigate Gd retention in patients requiring contrast-enhanced MRI. Te use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) has been ubiqui- tous in radiology for nearly three decades1. Recently however, it has come to light that the suboptimal biological stability of GBCAs can lead to accumulation of Gd in patients’ bone and brain tissue, as well as to kidney damage and associated systemic conditions due to compromised renal function2–4. -
Europium-DTPA: a Gadolinium Analogue Traceable by Fluorescence Microscopy
1137 Dyke Award Europium-DTPA: A Gadolinium Analogue Traceable by Fluorescence Microscopy Allen D. Elster1 A lanthanide series chelate, europium(Eu)-DTPA, was synthesized to serve as a Susan C. Jackels2 histochemical analogue for the widely used MR contrast agent gadolinium(Gd)-DTPA. Nina S. Allen3 Eu and Gd, being neighboring elements on the periodic table, share many fundamental Ron C. Marrache2 properties, including ionic radius, valence, and chemical reactivity. Eu-DTPA, however, possesses one important physical property not shared by Gd-DTPA: luminescence under ultraviolet light. The feasibility of detecting Eu-DTPA in animal tissues under fluorescence microscopy was systematically evaluated and documented. Distinctive orange-red luminescence of Eu-DTPA could be observed in the kidneys, livers, dura, choroid, and pituitary glands of rats after intravascular injection. No lumi nescence was detected in areas of brain beyond an intact blood-brain barrier. When the brain was locally injured by an experimental laceration, however, leakage of Eu-DTPA was detected. Electron probe microanalysis confirmed the parallel presence or absence of simultaneously injected Eu-DTPA and Gd-DTPA in all tissues studied. Fluorescence microscopy with Eu-DTPA has thus been validated as a method for tracing the distri bution of Gd-DTPA at the microscopic level. AJNR 10:1137-1144, November/December 1989 The recent development of paramagnetic MR contrast agents such as gadolinium (Gd)-DTPA has been received by the radiologic community with justifiable enthu siasm. Like their iodinated counterparts in CT, MR contrast agents appear to offer increased sensitivity and specificity for detecting and characterizing a number of diseases affecting the nervous system [1-11 ]. -
Electronic Structure Descriptor for the Discovery of Narrow-Band Red
Article pubs.acs.org/cm Electronic Structure Descriptor for the Discovery of Narrow-Band Red-Emitting Phosphors † † ‡ † Zhenbin Wang, Iek-Heng Chu, Fei Zhou, and Shyue Ping Ong*, † Department of NanoEngineering, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0448, United States ‡ Physics Division, Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, California 94550, United States *S Supporting Information ABSTRACT: Narrow-band red-emitting phosphors are a critical component of phosphor-converted light-emitting diodes for highly efficient illumination-grade lighting. In this work, we report the discovery of a quantitative descriptor for narrow-band Eu2+-activated emission identified through a comparison of the electronic structures of known narrow- band and broad-band phosphors. We find that a narrow emission bandwidth is characterized by a large splitting of more than 0.1 eV between the two highest Eu2+ 4f7 bands. By incorporating this descriptor in a high-throughput first- principles screening of 2259 nitride compounds, we identify five promising new nitride hosts for Eu2+-activated red-emitting phosphors that are predicted to exhibit good chemical stability, thermal quenching resistance, and quantum efficiency, as well as narrow-band emission. Our findings provide important insights into the emission characteristics of rare-earth activators in phosphor hosts and a general strategy to the discovery of phosphors with a desired emission peak and bandwidth. ■ INTRODUCTION activator concentration is found to have little influence on the 2+ Phosphor-converted light-emitting diodes (pc-LEDs) are an emission band position. The chemically similar CaLiAl3N4:Eu energy efficient and environmentally friendly lighting source for narrow-band red-emitting phosphor also has an emission peak 1−7 λ ∼ 6 solid-state lighting. -
Enriched Gadolinium As Burnable Absorber For
PHYSOR 2004 – The Physics of Fuel Cycles and Advanced Nuclear Systems: Global Developments Chicago, Illinois, April 25-29, 2004, on CD-ROM, American Nuclear Society, Lagrange Park, IL. (2004) Enriched Gadolinium as Burnable Absorber for PWR Klaes-Håkan Bejmer*1 and Ola Seveborn2 1Vattenfall Bränsle AB, S-162 87 Stockholm, Sweden 2Sernanders väg 5-518, S-752 61 Uppsala, Sweden Abstract This paper is a summary of a master of thesis work in reactor physics made by Ola Seveborn. The work was done at Vattenfall Bränsle AB and Ola was guided through the work by the corresponding author of this paper. The results presented are calculations for Ringhals 3, which is a Westinhouse 3- loop PWR within the Vattenfall Group. The fuel is characterized by 17x17 assemblies of AFA type containing 3.80-3.95 w/o 235U and 8 rods containing 2 w/o Gadolinium with an enrichment of 70 w/o 157Gd. The calculations were performed with the Studsvik-Scandpower code package based on the CASMO-4 lattice code and the SIMULATE-3 nodal code. The results are compared to the corresponding calculations for fuel with 5 w/o gadolinium with natural isotopic constitution. The depletion of the cores was done separately for the reference and enriched case. The results show that the gains in average for the five cycles studied are about 70 EFPH per cycle. This is an effect of the lower gadolinium content needed. Also less parasitic absorption of enriched gadolinium in the end of the fuel life contributes to the increased cycle lengths. The abruptly increased reactivity and internal power peaking factor around 10 MWd/kgU do not affect the core design negatively. -
DOCUMENT RESUME ED 071 911 SE 015 548 TITLE Project Physics
DOCUMENT RESUME ED 071 911 SE 015 548 TITLE Project Physics Teacher Guide 6, The Nucleus. INSTITUTION Harvard Univ., Cambridge, Mass. Harvard Project Physics. SPONS AGENCY Office of Education (DHEW) Washington, D.C. Bureau of Research. BUREAU NO BR-5-1038 PUB DATE 68 CONTRACT OEC-5-10-058 NOTE 235p.; Authorized Interim Version EDRS PRICE MF-$0.65 HC-S9.87 DESCRIPTORS Instructional Materials; *Multimedia Instruction; *Nuclear Physics; Physics; *Radiation; Science Activities; Secondary Grades; *Secondary School Science; *Teaching Glides; Teaching Procedures IDENTIFIERS Harvard Project Physics ABSTRACT Teaching procedures of Project Physics Unit 6are presented to help teachers make effectiveuse of learning materials. Unit contents are discussed in connection withteaching aid lists, multi-media schedules, schedule blocks, andresource charts. Brief summaries are made for transparencies, 16mm films, and reader articles. Included is information about the backgroundand development of each unit chapter, procedures in demonstrations, apparatus operations, notes on the student handbook, andan explanation of film loops. Additional articlesare concerned with objects dated by radiocarbon, radiation safety, propertiesof radiations, radioactive sources, radioactivity determinationby electroscopes, and radiation detecting devices.Scalers, counters, Geiger tubes, and cadmium selenide photocellsare analyzed; and a bibliography of references is given, Solutionsto the study guide are provided in detail, and answers to test itemsare suggested. The sixth unit of the text, with marginal commentson each section, is also compiled in the manual. The work of Harvard ProjectPhysics has . been financially supported by: the Carnegie Corporation ofNew York, the Ford Foundation, the National Science Foundation,the Alfred P. Sloan Foundation, the United States office of Education,and Harvard University.